PsychedeLinks is a weekly digest of news, business, and culture in the psychedelics industry curated by members of Emerge Law Group’s groundbreaking Psychedelics Industry Group.
Oregon Psilocybin Services Act
Oregon Psilocybin Rules Set To Be Finalized in December
The state of Oregon will soon have a regulatory framework for patients who want to try psilocybin as a medical treatment.
Coos County cities move to ban psilocybin for medical use in their communities
One of Oregon’s counties hasn’t stopped it’s fight against psilocybin showing up in its cities. Many have moved to put it to a vote in November.
Decriminalization, Legalization, & Other State Efforts
An initiative to decriminalize most plant-based psychedelics is likely to fall short on signatures
Another ballot initiative to legalize psychoactive mushrooms will go to voters in November.
San Francisco Will Consider Ending All Prosecution of Psychedelic Drug Use
The bill will hopefully reduce non-violent drug prosecution, and make it easier for health practitioners to utilize the therapeutic benefits.
GOP Congressman Is ‘Hopeful’ His Psychedelic Research Amendment Can Pass The Senate
Last week, a Republican congressman appeared on a Fox News podcast to express cautious optimism that the Senate will green-light his House-passed amendment to the National Defense Authorization Act (NDAA), which, if enacted, would allow the secretary of defense to approve grants for research into th…
World
A Legal Play for ‘Shrooms in Canada Could Make Waves in the US
A Canadian lawsuit over magic mushrooms could help spur the wave of liberalization the nascent industry has been pushing for. Filed in late July, the lawsuit challenges the Canadian federal government to make it easier for medical patients to get access to psilocybin, arguing that current regulations violate their constitutional rights.
Research, Science & Therapy
People Respond Differently to Psychedelic Drugs – Genetics Could be One Reason?
Studies have shown around one-third of people with mental health conditions like depression don’t respond to psychedelic-assisted treatment. Scientists aren’t entirely sure why, but new research suggests that genetic variations in a serotonin receptor may be a factor.
Business
An Inside Look into Field Trip’s Next-Generation Psychedelic, FT-104 | Psychedelic Spotlight
Field Trip is the only company exploring the therapeutic potential of a 4-HO-DiPT prodrug called FT-104. But how does it work?
Sports
How Aaron Rodgers’ ‘magic mushrooms’ and psychedelics led to his $200 million contract extension - The SportsRush
Aaron Rodgers has won back to back MVP awards, and he’s worked that level of play into a four-year, $200 million contract. He can credit his success to some unorthodox methods as well.
Culture
Towards Ego Transcendence: Can VR Produce Experiences Similar To Those Of Psychedelics?
A recent research article assessing ego identity reduction and increased feelings of connectedness found key insights regarding a potentially similar response in people subjected to a VR experience than those taking medium doses of LSD or magic mushrooms.
SXSW Opens Voting On Nearly 100 Marijuana And Psychedelics Panels For 2023 Festival
Voting is now open for the public to decide which panels will make the stage at next year’s South By Southwest (SXSW) festival—and there are about 100 marijuana- and psychedelics-related proposals to pick from. Drug policy topics have become a consistent feature of the Austin-based event in recent y…
Subscribe
Subscribe to PsychedeLinks to receive essential weekly articles on news, business, and culture in the psychedelics industry, delivered straight to your inbox.
